Question 1

Does STRS Ohio own BTAIQ stock?

Accepted Answer

No. STRS Ohio exited its BTAIQ (BioXcel Therapeutics) position in Q1 2021. Its Q4 2020 13F listed 4,000 shares worth $184,000.

Question 2

How many shares of BTAIQ does STRS Ohio own?

Accepted Answer

None since Q1 2021, when STRS Ohio exited the position. Its Q4 2020 13F listed 4,000 shares worth $184,000.

Question 3

What is STRS Ohio's BTAIQ position worth?

Accepted Answer

STRS Ohio's BTAIQ position was worth $184,000 in its Q4 2020 13F, before the exit in Q1 2021.

Question 4

Is STRS Ohio buying or selling BTAIQ?

Accepted Answer

In Q1 2021, STRS Ohio exited its entire BTAIQ position.

Question 5

When did STRS Ohio first buy BTAIQ?

Accepted Answer

STRS Ohio first reported BTAIQ in its Q2 2019 13F and listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$690.56	0
2020-Q4	Decreased	4,000	-62.3%	$184,000	0.0%	$739.20	0
2020-Q3	Unchanged	10,600	0.0%	$459,000	0.0%	$693.76	0
2020-Q2	Decreased	10,600	-15.9%	$561,000	0.0%	$848.16	0
2020-Q1	Increased	12,600	+48.2%	$281,000	0.0%	$357.60	32
2019-Q4	Unchanged	8,500	0.0%	$124,000	0.0%	$233.76	0
2019-Q3	Increased	8,500	+431.3%	$59,000	0.0%	$112.64	34
2019-Q2	New	1,600	-	$17,000	0.0%	$175.36	25